COVID-19 and comedications in atrial fibrillation—a case–control study in Stockholm

To test the main hypothesis that anticoagulation reduces risk of hospitalization, intensive care unit (ICU) admission and death in COVID-19. Nested case–control study among patients with atrial fibrillation (AF) in Stockholm. COVID-19 cases were matched to five disease-free controls with same sex, b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Max, Ekbom, Anders, Linder, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883132/
https://www.ncbi.nlm.nih.gov/pubmed/36707492
http://dx.doi.org/10.1007/s10654-023-00967-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883132/
https://www.ncbi.nlm.nih.gov/pubmed/36707492
http://dx.doi.org/10.1007/s10654-023-00967-9

Ejemplares similares